For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that ...
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.
The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...
One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for weight loss, and major food conglomerates are trying to cater to their ...
Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...
This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.